Physician profile
Emily Pond Wright
NPI 1144763079
$1,790.96
in general payments reported to CMS, 2019-2025
15 companies · $848 in 2025
The $848 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $122 · 2023: $125 · 2024: $543 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $446.97 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $380.09 | 2021-2025 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $164.81 | 2025 | Wavewriter Alpha Prime 16 |
| Exact Sciences Corporation | $164.18 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $162.16 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $135.85 | 2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $75.14 | 2024-2025 | Airsupra |
| Pfizer INC. | $74.44 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $73.18 | 2024-2025 | Rexulti |
| Spinal Simplicity, LLC | $29.66 | 2025 | Ha Minuteman G3-R |
| Amgen INC. | $20.24 | 2025 | |
| Xeris Pharmaceuticals, INC. | $20.11 | 2025 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $16.68 | 2024 | Eliquis |
| Astellas Pharma US INC | $15.90 | 2024 | Veozah |
| Horizon Therapeutics Plc | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.